Te hoge uitgaven door te grote doses in medicijnflesjes

Peter B Bach and colleagues call for an end to contradictory regulatory standards in the US that allow drug manufacturers to boost profits by producing single dose vials containing quantities that increase leftover drug.
Even though reducing waste in healthcare is a top priority, analysts have missed the waste that can be created when expensive infused drugs are packaged containing quantities larger than the amount needed. This is particularly true for drugs for which dosage is based on a patient’s weight or body size and that come in single dose packages. The article has a nice set of interactive infographics that show why cancer drug vial sizes cost billions (BMJ, 1 maart 2016).
Klik hier voor een stuk van het artikel en de infographics.
Klik hier voor meer informatie over de NVC E-Course Pharmaceutical Packaging.

Heeft u vragen over dit onderwerp, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411. Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update.